Emma Niméus

Lund University — Sweden

Medicine · Health Sciences

21h-index2.8kcitations182works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(79), Breast Cancer Treatment Studies(53), Immunotherapy and Immune Responses(50), Cancer Cells and Metastasis(35), Cancer Genomics and Diagnostics(29)

Publications182 total

Supplementary Tables S5-S11 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Figure S1 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Figure S5 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Figure S4 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Figure S3 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Tables S1-S4 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Study protocol S1 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Figure S2 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
PROCEM; A prospective randomized trial on the added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions
British journal of surgery·2025
Abstract P4-03-16: Comparison of analytical and prognostic performance among various Artificial Intelligence models for Tumor Infiltrating Lymphocytes scoring in Triple Negative Breast Cancer: An independent validation on a prospective cohort
Clinical Cancer Research·2025
Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial
Breast Cancer Research and Treatment·2025Open Access
Glucose-6-phosphate-dehydrogenase on old peroxisomes maintains self-renewal of epithelial stem cells after asymmetric cell division
Nature Communications·2025· 2 citedOpen Access
Human proteome distribution atlas for tissue-specific plasma proteome dynamics
Cell·2025· 32 citedOpen Access
Supplementary Table S5 from Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort
2025Open Access
Supplementary Figure S3 from Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort
2025Open Access
Supplementary Table S3 from Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort
2025Open Access
Data from Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort
2025Open Access
Supplementary Table S2 from Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort
2025Open Access
Supplementary Table S1 from Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort
2025Open Access
Supplementary Figure S2 from Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort
2025Open Access
page 1 of 10Next →

Frequent Co-authors

Martin Sjöström(15), Fredrika Killander(15), Tommaso De Marchi(13), Per Karlsson(12), Erik Holmberg(11), Mårten Fernö(10), Johan Staaf(10), Johan Hartman(9), Anna Ehinger(9), Johan Malmström(9), Axel Stenmark Tullberg(7), Ana Bosch(6), Dan Lundstedt(5), Anikó Kovács(5), Per Malmström(5), Lisa Rydén(5), Lars Malmström(5), Lena Tran(5), Ruedi Aebersold(4), Åke Borg(4)